National Pension Service Acquires 39,889 Shares of GE HealthCare Technologies Inc. $GEHC

National Pension Service grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 765,872 shares of the company’s stock after purchasing an additional 39,889 shares during the period. National Pension Service’s holdings in GE HealthCare Technologies were worth $62,817,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares in the last quarter. Dodge & Cox increased its position in shares of GE HealthCare Technologies by 16.8% in the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock valued at $2,066,550,000 after acquiring an additional 3,949,361 shares during the last quarter. Capital Research Global Investors increased its position in shares of GE HealthCare Technologies by 25.0% in the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after acquiring an additional 4,998,154 shares during the last quarter. Geode Capital Management LLC increased its position in shares of GE HealthCare Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock valued at $989,673,000 after acquiring an additional 37,159 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC increased its position in shares of GE HealthCare Technologies by 17.1% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock valued at $633,271,000 after acquiring an additional 1,232,828 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.8%

Shares of GEHC stock opened at $62.34 on Friday. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The stock has a market cap of $28.36 billion, a P/E ratio of 14.91, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The stock has a 50 day simple moving average of $67.68 and a 200 day simple moving average of $75.86. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter last year, the firm posted $1.01 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Insider Activity

In other GE HealthCare Technologies news, Director Rodney F. Hochman bought 1,618 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was purchased at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Watkin Phoebe L. Yang bought 1,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were acquired at an average price of $63.01 per share, with a total value of $63,010.00. Following the completion of the purchase, the director directly owned 13,702 shares of the company’s stock, valued at approximately $863,363.02. The trade was a 7.87% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders purchased 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on GEHC shares. Jefferies Financial Group lowered their price target on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Weiss Ratings cut GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and reduced their price objective for the stock from $75.00 to $69.00 in a report on Thursday, May 21st. HSBC reduced their price objective on GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Finally, Mizuho reduced their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $80.21.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.